Cargando…

The effect of ivermectin on the viral load and culture viability in early treatment of nonhospitalized patients with mild COVID-19 – a double-blind, randomized placebo-controlled trial

OBJECTIVES: Ivermectin, an antiparasitic agent, also has antiviral properties. In this study, we aimed to assess whether ivermectin has anti-SARS-CoV-2 activity. METHODS: In this double-blinded trial, we compared patients receiving ivermectin for 3 days versus placebo in nonhospitalized adult patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biber, Asaf, Harmelin, Geva, Lev, Dana, Ram, Li, Shaham, Amit, Nemet, Ital, Kliker, Limor, Erster, Oran, Mandelboim, Michal, Schwartz, Eli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262706/ https://www.ncbi.nlm.nih.gov/pubmed/35811080 http://dx.doi.org/10.1016/j.ijid.2022.07.003

Ejemplares similares

The role of mouthwash sampling in SARS-CoV-2 diagnosis
por: Biber, Asaf, et al.
Publicado: (2021)

Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection
por: Nemet, Ital, et al.
Publicado: (2021)

Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2
por: Lustig, Yaniv, et al.
Publicado: (2021)

The Rise and Fall of a Local SARS-CoV-2 Variant with the Spike Protein Mutation L452R
por: Mor, Orna, et al.
Publicado: (2021)

Outbreak of Influenza and Other Respiratory Viruses in Hospitalized Patients Alongside the SARS-CoV-2 Pandemic
por: Fratty, Ilana S., et al.
Publicado: (2022)

Cocirculation of A(H3N2) and B/Victoria increased morbidity in hospitalized patients in the 2019–2020 A(H1N1)pdm09 predominant influenza season in Israel
por: Jurkowicz, Menucha, et al.
Publicado: (2023)

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
por: Regev-Yochay, Gili, et al.
Publicado: (2022)

Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel
por: Lustig, Yaniv, et al.
Publicado: (2021)

Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022–2023 Winter Season
por: Moss, Stephen, et al.
Publicado: (2023)

Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients – implications for the omicron variant
por: Peled, Yael, et al.
Publicado: (2022)

COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022
por: Kliker, Limor, et al.
Publicado: (2022)

The impact of SARS-CoV-2 on respiratory syndromic and sentinel surveillance in Israel, 2020: a new perspective on established systems
por: Glatman-Freedman, Aharona, et al.
Publicado: (2022)

The SARS-CoV-2 Lambda variant and its neutralisation efficiency following vaccination with Comirnaty, Israel, April to June 2021
por: Zuckerman, Neta, et al.
Publicado: (2021)

Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant Recipients
por: Davidov, Yana, et al.
Publicado: (2023)

Reduced neutralization efficacy against SARS-CoV-2 Omicron variant after third boost of mRNA BNT162 vaccine among liver transplant recipients
por: Davidov, Yana, et al.
Publicado: (2022)

Immunology of Nonhospital and Intrahospital Infections
por: Zemskov, V. M., et al.
Publicado: (2021)

A Magnetic Modulation Biosensing-Based Molecular Assay for Rapid and Highly Sensitive Clinical Diagnosis of Coronavirus Disease 2019 (COVID-19)
por: Margulis, Michael, et al.
Publicado: (2021)

Viral co-pathogens in COVID-19 acute respiratory syndrome – what did we learn from the first year of pandemic?
por: Kriger, Or, et al.
Publicado: (2022)

Fourth BNT162b2 vaccination neutralization of omicron infection after heart transplantation
por: Peled, Yael, et al.
Publicado: (2022)

Evaluation of Adrenal Function in Nonhospitalized Patients with Cirrhosis
por: Moini, Maryam, et al.
Publicado: (2017)

Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2
por: Israeli, Ma’ayan, et al.
Publicado: (2022)

Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern
por: Chaouat, Abigael E., et al.
Publicado: (2022)

Overlooked monkeypox cases among men having sex with men during the 2022 outbreak – a retrospective study
por: Wieder-Feinsod, Anat, et al.
Publicado: (2023)

Colonoscopy quality in community hospitals and nonhospital facilities in Korea
por: Lee, Jae Gon, et al.
Publicado: (2021)

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
por: Jayk Bernal, Angélica, et al.
Publicado: (2021)

Thromboprophylaxis in hospitalized and nonhospitalized medical patients: what’s new?
por: Rezende, Suely M., et al.
Publicado: (2023)

Proof-of-concept for effective antiviral activity of an in silico designed decoy synthetic mRNA against SARS-CoV-2 in the Vero E6 cell-based infection model
por: Atari, Nofar, et al.
Publicado: (2023)

Does ivermectin have a place in the treatment of mild Covid-19?
por: Schwartz, Eli
Publicado: (2022)

Neurologic manifestations of nonhospitalized patients with COVID‐19 in Wuhan, China
por: Ding, Hong, et al.
Publicado: (2020)

Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19
por: Chhiba, Krishan D., et al.
Publicado: (2020)

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
por: Hammond, Jennifer, et al.
Publicado: (2022)

Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19
por: Fang, Margaret C., et al.
Publicado: (2023)

Unusual and Severe Complications of Acute Schistosomiasis in Travelers
por: Biber, Asaf, et al.
Publicado: (2022)

MRI Assessment of Cerebral Blood Flow in Nonhospitalized Adults Who Self‐Isolated Due to COVID‐19
por: Kim, William S. H., et al.
Publicado: (2022)

Comprehensive Analyses of SARS-CoV-2 Transmission in a Public Health Virology Laboratory
por: Zuckerman, Neta S., et al.
Publicado: (2020)

Genomic variation and epidemiology of SARS-CoV-2 importation and early circulation in Israel
por: Zuckerman, Neta S., et al.
Publicado: (2021)

Use of donor human milk in nonhospitalized infants: An infant growth study
por: Bramer, Solange, et al.
Publicado: (2021)

Oral Probenecid for Nonhospitalized Adults with Symptomatic Mild-to-Moderate COVID-19
por: Martin, David E., et al.
Publicado: (2023)

Predominance of a Drifted Influenza A (H3N2) Clade and Its Association with Age-Specific Influenza Vaccine Effectiveness Variations, Influenza Season 2018–2019
por: Glatman-Freedman, Aharona, et al.
Publicado: (2020)

Molecular characterization of the re-emerging West Nile virus in avian species and equids in Israel, 2018, and pathological description of the disease
por: Schvartz, Gili, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0j60nt07g0sjihm5ltp955uk0t